From a psychoevolutionary perspective, anger is a universal emotion that can serve the function of making us aware of wrongdoing and motivating us to undo/correct the wrongdoing. However, it is well recognized in clinical psychology that anger can be maladaptive, often causing distress and impairment in various areas of day-to-day life; untreated maladaptive anger has been found to raise the risk of certain physical health problems e.g., hypertension and coronary heart disease. At the very extreme, rage has been implicated in aggression and violence. Not surprisingly, there has been a widespread quest for anger treatments or what is popularly called "anger management". One treatment approach that has received increasing empirical support is Cognitive Behavioral Affective Therapy (CBAT), which has been applied to patients with chemical dependence and individuals with chronic pain. To extend this programmatic line of research, the proposed research aims to evaluate the efficacy of CBAT in reducing multiple (psychometric and self-monitored) measures of anger within a community sample.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Anger Parameters Scale (APS)
Timeframe: Baseline
Anger Parameters Scale (APS)
Timeframe: One-month
Anger Parameters Scale (APS)
Timeframe: One month after end of treatment program
Anger Expressions Scale (AES)
Timeframe: Baseline
Anger Expressions Scale (AES)
Timeframe: One-month
Anger Expressions Scale (AES)
Timeframe: One month after end of treatment program
Self-Monitored Anger (Anger Log)
Timeframe: Baseline up to 4 weeks
Self-Monitored Anger (Anger Log)
Timeframe: One week after the interim period